Equities Analysts Set Expectations for McKesson Co.’s FY2026 Earnings (NYSE:MCK)

McKesson Co. (NYSE:MCK) – Stock analysts at Leerink Partnrs cut their FY2026 earnings per share estimates for McKesson in a research report issued to clients and investors on Monday, October 7th. Leerink Partnrs analyst M. Cherny now anticipates that the company will earn $35.93 per share for the year, down from their previous estimate of $36.03. The consensus estimate for McKesson’s current full-year earnings is $32.07 per share. Leerink Partnrs also issued estimates for McKesson’s FY2028 earnings at $45.42 EPS.

Several other equities research analysts have also issued reports on the company. StockNews.com lowered McKesson from a “buy” rating to a “hold” rating in a research note on Friday, September 27th. Leerink Partners lowered their target price on McKesson from $665.00 to $630.00 and set an “outperform” rating for the company in a research note on Monday. Barclays boosted their price target on McKesson from $596.00 to $616.00 and gave the company an “overweight” rating in a report on Thursday, August 8th. JPMorgan Chase & Co. boosted their price target on McKesson from $656.00 to $661.00 and gave the company an “overweight” rating in a report on Wednesday, August 21st. Finally, Deutsche Bank Aktiengesellschaft decreased their target price on McKesson from $623.00 to $579.00 and set a “buy” rating for the company in a research report on Wednesday, September 25th. Five investment analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $610.86.

McKesson Stock Performance

Shares of NYSE MCK opened at $495.09 on Wednesday. The stock has a market cap of $64.33 billion, a PE ratio of 22.12, a price-to-earnings-growth ratio of 1.18 and a beta of 0.44. McKesson has a fifty-two week low of $431.35 and a fifty-two week high of $637.51. The stock has a fifty day moving average of $535.98 and a 200-day moving average of $553.73.

McKesson (NYSE:MCK) last announced its quarterly earnings data on Wednesday, August 7th. The company reported $7.88 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.21 by $0.67. The business had revenue of $79.28 billion for the quarter, compared to analysts’ expectations of $82.53 billion. McKesson had a negative return on equity of 242.57% and a net margin of 0.94%. The firm’s quarterly revenue was up 6.4% compared to the same quarter last year. During the same period in the previous year, the business posted $7.27 EPS.

McKesson Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, October 1st. Investors of record on Monday, September 2nd were given a dividend of $0.71 per share. The ex-dividend date of this dividend was Friday, August 30th. This is an increase from McKesson’s previous quarterly dividend of $0.62. This represents a $2.84 annualized dividend and a yield of 0.57%. McKesson’s payout ratio is 12.69%.

Insider Buying and Selling at McKesson

In other news, CEO Brian S. Tyler sold 3,753 shares of McKesson stock in a transaction dated Thursday, September 5th. The stock was sold at an average price of $561.10, for a total value of $2,105,808.30. Following the sale, the chief executive officer now directly owns 78,586 shares of the company’s stock, valued at approximately $44,094,604.60. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 0.11% of the company’s stock.

Institutional Investors Weigh In On McKesson

Several large investors have recently made changes to their positions in the company. LRI Investments LLC purchased a new position in shares of McKesson during the first quarter valued at approximately $28,000. Register Financial Advisors LLC acquired a new position in shares of McKesson in the 1st quarter valued at $29,000. Richardson Financial Services Inc. acquired a new position in shares of McKesson in the 4th quarter valued at $31,000. Rise Advisors LLC acquired a new position in shares of McKesson in the 1st quarter valued at $40,000. Finally, Carmichael Hill & Associates Inc. acquired a new position in shares of McKesson in the 2nd quarter valued at $52,000. 85.07% of the stock is owned by institutional investors.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.